129 related articles for article (PubMed ID: 8617478)
1. Differential expression of the bcl-2 oncogene in human basal cell carcinoma.
Crowson AN; Magro CM; Kadin ME; Stranc M
Hum Pathol; 1996 Apr; 27(4):355-9. PubMed ID: 8617478
[TBL] [Abstract][Full Text] [Related]
2. bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.
Ramdial PK; Madaree A; Reddy R; Chetty R
J Cutan Pathol; 2000 Jul; 27(6):283-91. PubMed ID: 10885404
[TBL] [Abstract][Full Text] [Related]
3. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
[TBL] [Abstract][Full Text] [Related]
4. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
5. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
Bartoš V
Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.
Vidal D; Matías-Guiu X; Alomar A
Br J Dermatol; 2004 Sep; 151(3):656-62. PubMed ID: 15377354
[TBL] [Abstract][Full Text] [Related]
7. Analysis of p53 and BAX mutations, loss of heterozygosity, p53 and BCL2 expression and apoptosis in basal cell carcinoma in Korean patients.
Cho S; Hahm JH; Hong YS
Br J Dermatol; 2001 Apr; 144(4):841-8. PubMed ID: 11298546
[TBL] [Abstract][Full Text] [Related]
8. BAX protein is not expressed by basal cell carcinomas.
Rossen K; Karabulut Thorup A; Hou-Jensen K; Krag Jacobsen G
Br J Dermatol; 1998 Sep; 139(3):472-4. PubMed ID: 9767293
[TBL] [Abstract][Full Text] [Related]
9. bcl-2 expression in primary malignancies of the skin.
Morales-Ducret CR; van de Rijn M; LeBrun DP; Smoller BR
Arch Dermatol; 1995 Aug; 131(8):909-12. PubMed ID: 7632062
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis.
Shi FT; Yu M; Zloty D; Bell RH; Wang E; Akhoundsadegh N; Leung G; Haegert A; Carr N; Shapiro J; McElwee KJ
Mol Med Rep; 2017 Apr; 15(4):1441-1454. PubMed ID: 28259916
[TBL] [Abstract][Full Text] [Related]
12. Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.
Freier K; Flechtenmacher C; Devens F; Hartschuh W; Hofele C; Lichter P; Joos S
Oncol Rep; 2006 May; 15(5):1141-5. PubMed ID: 16596176
[TBL] [Abstract][Full Text] [Related]
13. [Expression of bcl-2, bax and p53 protein in the basal cell carcinoma].
Yan L; Chen M; Yu G
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):179-80. PubMed ID: 11938785
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
Bartoš V; Kullová M
Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
[TBL] [Abstract][Full Text] [Related]
16. Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer.
Verhaegh ME; Sanders CJ; Arends JW; Neumann HA
Br J Dermatol; 1995 May; 132(5):740-4. PubMed ID: 7772478
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
Mateoiu C; Pirici A; Bogdan F
Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
20. Merkel cells and Merkel cell carcinoma express the BCL-2 proto-oncogene.
Plettenberg A; Pammer J; Tschachler E
Exp Dermatol; 1996 Apr; 5(2):102-7. PubMed ID: 8734919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
